Quince Therapeutics Inc
General ticker "QNCX" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $85.2M
Quince Therapeutics Inc follows the US Stock Market performance with the rate: 9.1%.
Estimated limits based on current volatility of 4.5%: low 1.68$, high 1.84$
Factors to consider:
- Earnings for 9 months up through Q3 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [0.93$, 2.44$]
- 2024-12-30 to 2025-12-30 estimated range: [0.82$, 2.14$]
Financial Metrics affecting the QNCX estimates:
- Negative: Non-GAAP EPS, $ of -0.84 <= 0.10
- Negative: Operating profit margin, % of -100 <= 1.03
- Negative: Operating cash flow per share per price, % of -32.49 <= 2.35
- Positive: -0.96 < Investing cash flow per share, $ of -0.15
- Negative: negative Net income
- Positive: Industry inventory ratio change (median), % of 0 <= 0
- Negative: Industry operating cash flow per share per price (median), % of -23.87 <= 3.85
Short-term QNCX quotes
Long-term QNCX plot with estimates
Financial data
| YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|
| Operating Revenue | $0.00MM | $0.00MM | $0.00MM |
| Operating Expenses | $90.32MM | $52.02MM | $34.62MM |
| Operating Income | $-90.32MM | $-52.02MM | $-34.62MM |
| Non-Operating Income | $0.37MM | $0.07MM | $3.04MM |
| Interest Expense | $0.00MM | $0.57MM | $0.00MM |
| R&D Expense | $60.80MM | $25.18MM | $9.45MM |
| Income(Loss) | $-89.94MM | $-51.94MM | $-31.58MM |
| Taxes | $0.00MM | $-0.28MM | $-0.20MM |
| Profit(Loss) | $-89.94MM | $-51.66MM | $-31.39MM |
| Stockholders Equity | $118.59MM | $100.59MM | $85.08MM |
| Inventory | $2.25MM | $2.29MM | $0.00MM |
| Assets | $133.23MM | $103.91MM | $167.90MM |
| Operating Cash Flow | $-62.93MM | $-44.04MM | $-18.29MM |
| Capital expenditure | $0.18MM | $0.13MM | $0.16MM |
| Investing Cash Flow | $58.95MM | $18.00MM | $-5.76MM |
| Financing Cash Flow | $6.81MM | $0.71MM | $0.14MM |
| Earnings Per Share* | $-3.01 | $-1.54 | $-0.84 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.